SelectScience InterviewsDrug Discovery & Development
Humanized mice for therapeutic target validation
11 Sept 2024Cameron Smith-Craig
Associate Editor
Dr. Ali Roghanian, Associate Professor at the University of Southampton, explains why better mouse models are needed to bridge the gap between bench to bedside. Exploring existing syngeneic models and how their inherent limitations could be overcome, Dr. Roghanian shares his group’s research using a disseminate model of human breast cancer in humanized mice.
This video was filmed in partnership with The Jackson Laboratory.